Literature DB >> 9548016

The cellular biology of B-cell chronic lymphocytic leukemia.

J Jurlander1.   

Abstract

In conclusion, B-CLL cells through their immunophenotype have the functional potential required to interact with cells in what has been called the immunological synapse, i.e. the cognate interactions between T-cells, antigen-presenting cells and B-cells during immunopoiesis. The data reviewed herein provides substantial evidence to suggest that B-CLL cells in fact can interact, not only with T-cells but also with endothelial cells and stromal cells in the bone marrow. These interactions, in particular signaling through CD40, contribute to extended survival and proliferation of B-CLL cells and, thereby, the risk of complete malignant transformation of the clone. Therefore, this review would suggest that the answers to how B-CLL is initiated may be found in molecules responsible for the normal regulation of immunopoiesis. Transformation to malignancy, by contrast, is likely to be caused by loss of control over the G1 restriction in the cell cycle in B-CLL cells.

Entities:  

Mesh:

Year:  1998        PMID: 9548016     DOI: 10.1016/s1040-8428(97)10008-7

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  6 in total

1.  Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2.

Authors:  C Pepper; J G Mahdi; A G S Buggins; S Hewamana; E Walsby; E Mahdi; A Al-Haza'a; A J Mahdi; T T Lin; L Pearce; L Morgan; I D Bowen; P Brennan; C Fegan
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

2.  Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha.

Authors:  Mitsufumi Nishio; Tomoyuki Endo; Nobuhiro Tsukada; Junko Ohata; Shinichi Kitada; John C Reed; Nathan J Zvaifler; Thomas J Kipps
Journal:  Blood       Date:  2005-04-28       Impact factor: 22.113

3.  Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells.

Authors:  M S Gordon; R M Kato; F Lansigan; A A Thompson; R Wall; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  DNA repair initiation induces expression of ribonucleotide reductase in human chronic lymphocytic leukemia cells.

Authors:  Martha Rodriguez Sandoval; Kumudha Balakrishnan; Rajyalakshmi Luthra; Michael Keating; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2013-07-29

5.  Endobronchial deposits of chronic lymphocytic leukemia - an unusual cause of central airway obstruction.

Authors:  Miranda Maw; Michael Harvey; Zinta Harrington; Melissa Baraket; Renn Montgomery; Jonathan Williamson
Journal:  Respirol Case Rep       Date:  2015-02-25

6.  Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia.

Authors:  A Olsson; M Norberg; A Okvist; K Derkow; A Choudhury; G Tobin; F Celsing; A Osterborg; R Rosenquist; M Jondal; L M Osorio
Journal:  Br J Cancer       Date:  2007-08-28       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.